Cell Line : HS934.T
Cellosaurus Index : CVCL_1031
Cellosaurus ID : HS934.T
CTRP2 Name
: HS934T
CCLE Name
: HS934T_FIBROBLAST
Cancer Type : skin
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HS934.T | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| HS934.T | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| HS934.T | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HS934.T | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | BRD-K01737880 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HS934.T | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| HS934.T | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | BRD-K41597374 | CTRP2 | 0.0020 | 67.0000 |
|
| HS934.T | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HS934.T | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| HS934.T | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HS934.T | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| HS934.T | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| HS934.T | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| HS934.T | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HS934.T | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| HS934.T | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| HS934.T | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | MIRA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | ML311 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| HS934.T | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HS934.T | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| HS934.T | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| HS934.T | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| HS934.T | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| HS934.T | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| HS934.T | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HS934.T | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| HS934.T | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HS934.T | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| HS934.T | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HS934.T | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| HS934.T | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| HS934.T | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS934.T | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HS934.T | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS934.T | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HS934.T | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HS934.T | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| HS934.T | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| HS934.T | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HS934.T | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HS934.T | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| HS934.T | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| HS934.T | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| HS934.T | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC